FENC
Price
$8.25
Change
-$0.03 (-0.36%)
Updated
Jun 27 closing price
Capitalization
228.52M
38 days until earnings call
IRD
Price
$0.98
Change
-$0.04 (-3.92%)
Updated
Jun 27 closing price
Capitalization
58.27M
Interact to see
Advertisement

FENC vs IRD

Header iconFENC vs IRD Comparison
Open Charts FENC vs IRDBanner chart's image
Fennec Pharmaceuticals
Price$8.25
Change-$0.03 (-0.36%)
Volume$196.82K
Capitalization228.52M
Opus Genetics
Price$0.98
Change-$0.04 (-3.92%)
Volume$788.06K
Capitalization58.27M
FENC vs IRD Comparison Chart in %
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FENC vs. IRD commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a Buy and IRD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (FENC: $8.25 vs. IRD: $0.98)
Brand notoriety: FENC and IRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 224% vs. IRD: 59%
Market capitalization -- FENC: $228.52M vs. IRD: $58.27M
FENC [@Biotechnology] is valued at $228.52M. IRD’s [@Biotechnology] market capitalization is $58.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whileIRD’s FA Score has 0 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • IRD’s FA Score: 0 green, 5 red.
According to our system of comparison, FENC is a better buy in the long-term than IRD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 1 TA indicator(s) are bullish while IRD’s TA Score has 4 bullish TA indicator(s).

  • FENC’s TA Score: 1 bullish, 5 bearish.
  • IRD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IRD is a better buy in the short-term than FENC.

Price Growth

FENC (@Biotechnology) experienced а +6.31% price change this week, while IRD (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

FENC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($229M) has a higher market cap than IRD($58.3M). FENC YTD gains are higher at: 30.538 vs. IRD (-17.933). FENC has higher annual earnings (EBITDA): -10.34M vs. IRD (-57.23M). IRD has more cash in the bank: 41.8M vs. FENC (22.7M). FENC has higher revenues than IRD: FENC (30.9M) vs IRD (13.7M).
FENCIRDFENC / IRD
Capitalization229M58.3M393%
EBITDA-10.34M-57.23M18%
Gain YTD30.538-17.933-170%
P/E Ratio60.43N/A-
Revenue30.9M13.7M226%
Total Cash22.7M41.8M54%
Total Debt19.4MN/A-
FUNDAMENTALS RATINGS
FENC vs IRD: Fundamental Ratings
FENC
IRD
OUTLOOK RATING
1..100
5049
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
86100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4279
P/E GROWTH RATING
1..100
9898
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRD's Valuation (68) in the null industry is in the same range as FENC (90) in the Biotechnology industry. This means that IRD’s stock grew similarly to FENC’s over the last 12 months.

FENC's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as IRD (100) in the null industry. This means that FENC’s stock grew similarly to IRD’s over the last 12 months.

FENC's SMR Rating (100) in the Biotechnology industry is in the same range as IRD (100) in the null industry. This means that FENC’s stock grew similarly to IRD’s over the last 12 months.

FENC's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for IRD (79) in the null industry. This means that FENC’s stock grew somewhat faster than IRD’s over the last 12 months.

FENC's P/E Growth Rating (98) in the Biotechnology industry is in the same range as IRD (98) in the null industry. This means that FENC’s stock grew similarly to IRD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FENCIRD
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPMF172.955.08
+3.03%
Capgemini SE
CERGF4.35N/A
N/A
Ceres Global Ag Corp.
PADEF0.11N/A
N/A
PT ALAMTRI RES INDONESIA TBK
SOHOF0.06N/A
N/A
Soho China, Ltd.
SNHO0.19-0.37
-65.84%
SHONGHOYA INTL GROUP INC.

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-0.36%
DNLI - FENC
48%
Loosely correlated
-2.69%
CLDX - FENC
45%
Loosely correlated
-4.16%
IDYA - FENC
44%
Loosely correlated
-4.13%
BEAM - FENC
44%
Loosely correlated
-1.98%
ATXS - FENC
43%
Loosely correlated
N/A
More

IRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with INO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-4.25%
INO - IRD
39%
Loosely correlated
-6.22%
FENC - IRD
36%
Loosely correlated
-0.36%
TERN - IRD
33%
Poorly correlated
-4.25%
UNCY - IRD
33%
Poorly correlated
+14.48%
GBIO - IRD
32%
Poorly correlated
-15.40%
More